Niguldipine

From WikiMD's WELLNESSPEDIA


Chemical structure of Niguldipine

Niguldipine is a calcium channel blocker that belongs to the dihydropyridine class of medications. It is primarily used in the management of hypertension and angina pectoris. As a calcium channel blocker, niguldipine works by inhibiting the influx of calcium ions through L-type calcium channels, which are found in the smooth muscle cells of the vascular system and the myocardium.

Mechanism of Action[edit]

Niguldipine exerts its effects by selectively blocking L-type calcium channels. These channels are responsible for the influx of calcium ions into cells, which is a critical step in the contraction of smooth muscle and cardiac muscle. By inhibiting these channels, niguldipine causes relaxation of vascular smooth muscle, leading to vasodilation and a subsequent decrease in blood pressure. This action also reduces the workload on the heart, making it effective in treating angina.

Pharmacokinetics[edit]

Niguldipine is administered orally and is well absorbed from the gastrointestinal tract. It undergoes extensive first-pass metabolism in the liver, which affects its bioavailability. The drug is highly protein-bound in the bloodstream and is metabolized primarily by the cytochrome P450 enzyme system. The metabolites are excreted in the urine and feces.

Clinical Uses[edit]

Niguldipine is used in the treatment of:

Side Effects[edit]

Common side effects of niguldipine include:

Less common but serious side effects may include:

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.